feed,title,long_url,short_url
Investors,Bristol Myers Sheds 6% After Promising Schizophrenia Drug Flops In Phase 3 Test,https://www.investors.com/news/technology/bristol-myers-squibb-cobenfy-adjunctive-treatment-schizophrenia/,https://da.gd/bOI9I
Investors,SAP Earnings Top Views On Strong Cloud Computing Growth,https://www.investors.com/news/technology/sap-stock-sap-earnings-news-q12025/,https://da.gd/GvQDhq
